We comply with the
HONcode standard for trustworthy health information:
verify here

162 Participating Centers in 33 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net (funded by the 6th Framework Program of the European Community)

News

EUTOS: Updated physician´s information

Updated physician´s information from the EUTOS for CML project

PP-Slides for promoting the ELN network

Download the Power Point slides - free for use - to promote the ELN Network

Registry of CML patients in failure after Imatinib

Although imatinib is now the first line therapy for chronic myelogenous leukemia patients, experimental and clinical studies suggest that imatinib as a single drug might not be sufficient to eradicate Ph-positive stem cells.

Events
Tu 2009/07/07 Multidisciplinary Workshop on A Single CTA in Multinational Clinical Trials "A single CTA in Multinational Clinical Trials Dream or Option?" is one multidisciplinary Workshop organized by the European···
We 2009/07/08 Symposium on ANAEMIA IN THE OLDER PERSON: A SILENT EPIDEMIC
Fr 2009/09/11 - Su 2009/09/13 ESH Eleventh International Conference: CHRONIC MYELOID LEUKAEMIA - Biological Basis of Therapy
We 2009/10/14 - Fr 2009/10/16 IACRLRD Symposium XXIV Molecular Approaches to Leukemia in the 21st Century: Biology, Outcome Prediction and Personalized Therapy
Th 2009/10/22 - Su 2009/10/25 ESH Conference: MYELODYSPLASTIC SYNDROMES

The European Leukemia Net

The objective is to integrate the 78 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 83 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care more...

leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה,

Dates & Meetings

July 2009

« | »

August 2009

« | »

RSS

Online Registration

How to join the European LeukemiaNet

European Leukemia Trial Registry (ELTR)

European Treatment and Outcome Study

EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe